In vitro effects of free 211At, 211At-albumin and 211At-monoclonal antibody compared to external photon irradiation on two human cancer cell lines

Anticancer Research

Volumn 20, Issue 2 A, 2000, Pages 1005-1012

  Palm, Stig ^a   Andersson, HÅKAN ^a   Bäck, Tom ^a   Claesson, Ingela ^a   Delle, Ulla ^a   Hultborn, Ragnar ^a   Jacobsson, Lars ^a   Köpf, Istvan ^a   Lindegren, Sture ^a,b  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b CHALMERS UNIVERSITY OF TECHNOLOGY   (Sweden)

Author keywords

Alpha particles; At 211; In vitro effects; Monoclonal antibodies; Radioimmunotherapy; RBE

Indexed keywords

ALBUMIN; ASTATINE 211; MONOCLONAL ANTIBODY;

ARTICLE; BINDING SITE; CANCER CELL CULTURE; CELL FRACTIONATION; CELL SURVIVAL; CELL SUSPENSION; CENTRIFUGATION; CONTROLLED STUDY; CULTURE MEDIUM; ENERGY TRANSFER; HUMAN; HUMAN CELL; LIGHT EXPOSURE; PRIORITY JOURNAL; RADIOIMMUNOTHERAPY;

ANTIBODIES, MONOCLONAL; ASTATINE; CELL DIVISION; CELL NUCLEUS; CELL SIZE; CELL SURVIVAL; COLONIC NEOPLASMS; FEMALE; HUMANS; OVARIAN NEOPLASMS; PHOTONS; RADIOIMMUNOTHERAPY; RADIOPHARMACEUTICALS; TUMOR CELLS, CULTURED;

EID: 0034054742     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Cunningham SH, Mairs RJ, Wheldon TE, Welsh PC, Vaidyanathan G and Zalutsky MR: Toxicity to neuroblastoma cells and spheroids of benzylguanidine conjugated to radionuclides with short-range emissions. Br J Cancer 77: 2061-2068, 1918.
2. Link EM, Michalowski AS and Rosch F: 211At-methylene blue for targeted radiotherapy of disseminated melanoma: microscopic analysis of tumour versus normal tissue damage. Eur J Cancer 32A: 1486-1994, 1996.
3. McDevitt MR, Sgouros G, Finn RD, Humm JL, Jurcic JG, Larson SM and Scheinberg DA: Radioimmunotherapy with alpha-emitting nuclides. Eur J Nucl Med 25: 1341-1351, 1998.
4. Vaidyanathan G, Larsen RH and Zalutsky MR: 5-[211 At]astato-2'-deoxyuridine, an alpha particle-emitting endoradiotherapeutic agent undergoing DNA incorporation. Cancer Res 56: 1204-1209, 1996.
5. Vaidyanathan G, Zhao XG, Larsen RH and Zalutsky MR: 3-[211At]astato-4 fluorobenzylguanidine: a potential therapeutic agent with prolonged retention by neuroblastoma cells. Br J Cancer 76: 226-233, 1997.
6. Wunderlich G, Franke WG, Doberenz I and Fischer S: Two ways to establish potential At-211 radiopharmaceuticals. Anticancer Res 17: 1809-1813, 1997.
7. International commission on radiation units and measurements: Stopping powers and ranges for protons and alpha particles. ICRU report 49. Bethesda Maryland), ICRU, 1993.
8. Kassis AI, Harris CR, Adelstein SJ, Ruth TJ, Lambrecht R, Wolf AP: The in vitro radiobiology of astatine-211 decay. Radiat Res 105: 27-36, 1986.
9. Zalutsky MR, McLendon RE, Garg PK, Archer GE, Schuster JM, Bigner DD: Radioimmunotherapy of neoplastic meningitis in rats using an α-particle-emitting immunoconjugate. Cancer Res 54: 4719-4725, 1994.
10. 211At-TP-3 monoclonal antibody: comparison with astatine-211-labelled bovine serum albumin, free astatine-211 and external-beam X rays. Radiat Res 139: 178-184, 1994.
11. 211At-astatinated endoradiotherapeutic drug: Part II. Therapeutic results for transplanted adcnocarcinoma of the rectum in mice and associated studies. Int J Radiat Oncol Biol Phys 29: 115-124, 1994.
12. Palm S, Bäck T, Claesson I, Delle U, Hultborn R, Jacobsson L, Köpf I, Lindegren S: Effects of the alpha-particle emitter At-211 and low-dose-rate gamma-radiation on the human cell line Colo-205 as studied with a growth assay. Anticancer Res 18: 1671-1676, 1998.
13. 2. Nucl Med Biol 20: 917-928, 1993.
14. 211At]-astatination of antibodies. Submitted.
15. 211At]Astato-3-Pyridinecarboxylate. Nucl Med Biol 26: 405-411, 1999.
16. Kueng W, Silber E, Eppenberger U: Quantification of cells cultured on 96-well plates. Anal Biochem 182: 16-19, 1989.
17. Yang Y, Olofsson M, Köpf I, Hultborn R: Growth and clonogenic assays compared for irradiated MCF-7 and Colo-205 cell lines. Anticancer Res 18: 53-59, 1998.
18. 211At-monoclonal antibody on two human cancer cell lines. Submitted.
19. Berei K, Vasáros L: Recent advances in the organic chemistry of astatine. In: The Chemistry of Halides, Pseudo-halides and Azides Patai S and Rappoport Z, eds). New York, Wiley, 1995, pp 787-818.
20. 211At-labelled monoclonal antibody Mov 18. Submitted.